Correlation Between PaxMedica, Common and Cingulate Warrants
Can any of the company-specific risk be diversified away by investing in both PaxMedica, Common and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PaxMedica, Common and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PaxMedica, Common Stock and Cingulate Warrants, you can compare the effects of market volatilities on PaxMedica, Common and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PaxMedica, Common with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of PaxMedica, Common and Cingulate Warrants.
Diversification Opportunities for PaxMedica, Common and Cingulate Warrants
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between PaxMedica, and Cingulate is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding PaxMedica, Common Stock and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and PaxMedica, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PaxMedica, Common Stock are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of PaxMedica, Common i.e., PaxMedica, Common and Cingulate Warrants go up and down completely randomly.
Pair Corralation between PaxMedica, Common and Cingulate Warrants
Given the investment horizon of 90 days PaxMedica, Common Stock is expected to under-perform the Cingulate Warrants. But the pink sheet apears to be less risky and, when comparing its historical volatility, PaxMedica, Common Stock is 13.68 times less risky than Cingulate Warrants. The pink sheet trades about -0.01 of its potential returns per unit of risk. The Cingulate Warrants is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 27.00 in Cingulate Warrants on September 10, 2024 and sell it today you would lose (23.45) from holding Cingulate Warrants or give up 86.85% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 39.78% |
Values | Daily Returns |
PaxMedica, Common Stock vs. Cingulate Warrants
Performance |
Timeline |
PaxMedica, Common Stock |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cingulate Warrants |
PaxMedica, Common and Cingulate Warrants Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PaxMedica, Common and Cingulate Warrants
The main advantage of trading using opposite PaxMedica, Common and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PaxMedica, Common position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.PaxMedica, Common vs. Quoin Pharmaceuticals Ltd | PaxMedica, Common vs. Revelation Biosciences | PaxMedica, Common vs. Unicycive Therapeutics | PaxMedica, Common vs. Cardio Diagnostics Holdings |
Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |